EP3254681
N-(5S,6S,9R)-5-AMINO-6-(2,3-DIFLUOROPHENYL)-6,7,8,9-TETRAHYDRO-5H-CYCLOHEPTA[B]PYRIDIN-9-YL-4-(2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-B]PYRIDIN-1-YL)PIPERIDINE-1-CARBOXYLATE SALT
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
25.2.2013EP published:
19.6.2019EP application number:
17180587.2
EPO information:
European Patent Register
Max expiry date:
24.2.2033
Title:
N-(5S,6S,9R)-5-AMINO-6-(2,3-DIFLUOROPHENYL)-6,7,8,9-TETRAHYDRO-5H-CYCLOHEPTA[B]PYRIDIN-9-YL-4-(2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-B]PYRIDIN-1-YL)PIPERIDINE-1-CARBOXYLATE SALT
Timeline
Today
25.2.2013EP application
19.6.2019EP Publication
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, 08543, Princeton, NJ, US
Inventor
Name:
ROBERTS, Daniel RichardAddress:
New Brunswick, NJ New Jersey, US
Name:
SCHARTMAN, Richard RaymondAddress:
Wallingford, CT Connecticut, US
Name:
WEI, ChenkouAddress:
New Brunswick, NJ New Jersey, US
Priority
Number:
201261603598 PDate:
27.2.2012Country:
US
Classification
Categories:
A61K 31/437, C07D 471/04, A61P 11/00, A61P 25/00